ArticleBiochemical and biophysical research communications2025
Non-Ser36 phosphorylated p66Shc inhibits TRPC-dependent and TRPC-independent calcium influx in vascular smooth muscle cells.
Article in Biochemical and biophysical research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Hypertension is a highly prevalent condition that causes chronic kidney disease and eventually kidney failure. Increased expression of adaptor protein p66Shc has been associated with attenuated vascular responses to stimuli and renal damage in hypertensive Dahl salt-sensitive (SS) rats. Reduced contractility of renal microvessels was linked to inhibition of calcium influx through transient receptor canonical (TRPC) channels in vascular smooth muscle cells (SMCs). Prevention of Ser36 phosphorylation of p66Shc, which stimulates mitochondrial translocation, exaggerated modulation of TRPC activity. While TRPC inhibition was dependent on p66Shc expression, the underlying mechanism is unresolved. The expression profiles of TRPCs in rat renal SMCs from Dahl-SS and mutant rats were determined. Confocal imaging with Fluo4-AM was used to assess calcium entry in response to various stimuli, and TRPC inhibitors were used to evaluate relative contributions of different channels. Endothelin-mediated calcium influx was primarily driven by TRPC6. Direct activation of TRPC6 by Oleoyl-acetyl-sn-glycerol was possible in SMCs expressing wild-type p66Shc but was greatly suppressed in cells expressing S36A mutant p66Shc, suggesting TRPC inhibition by p66Shc is independent of Ser36 phosphorylation. P66Shc inhibited calcium entry independent of TRPCs in response to ATP, indicating broad control of calcium dynamics by p66Shc. Overall, these results provide insight into p66Shc regulation of calcium entry that contributes to impaired vascular responses in hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.